Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Reporter India.
Press releases published on June 2, 2025
AST Launches Enhanced 2025 Industry Patent Purchase Program (IP3) with Group Licensing Option
EIN Presswire
·
June 2, 2025
AST launched its 10th annual IP3 initiative for 2025, connecting patent owners with leading technology companies for streamlined transactions. PRINCETON, NJ, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Allied Security Trust (AST), a member-driven …
PayToMe.co Joins NVIDIA Inception to Tackle $46B SMB Finance Problem With AI
EIN Presswire
·
June 2, 2025
NVIDIA Inception supports PayToMe.co’s mission to empower 400M SMBs with real-time payments, compliance automation, and global AI infrastructure. SAN FRANCISCO, CA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- 🚀 PayToMe.co, an award-winning AI- …
Dr. Ushma Kakkad Earns Certification in Conscious Sedation with Nitrous Oxide from IDA
EIN Presswire
·
June 2, 2025
Certification empowers Dr. Kakkad to offer anxiety-free dental care using nitrous oxide for kids and adults at Summirow Dental Hospital. SURAT, GUJARAT, INDIA, June 2, 2025 /EINPresswire.com/ -- Introduction We’re proud to share some exciting news from …
Niemann-Pick Disease Market Insights: Key Trends and Developments Across Different Types of Niemann-Pick Disease | DelveInsight
GlobeNewswire
·
June 2, 2025
New York, USA, June 02, 2025 (GLOBE NEWSWIRE) -- Niemann-Pick Disease Market Insights: Key Trends and Developments Across Different Types of Niemann-Pick Disease | DelveInsight According to DelveInsight’s analysis, the market for Niemann-Pick disease is …
Cancer mRNA Vaccine Clinical Trials FDA Approval mRNA Therapies Clinical Advances Insight
GlobeNewswire
·
June 2, 2025
Delhi, June 02, 2025 (GLOBE NEWSWIRE) -- mRNA cancer vaccines approach clinical maturity, the commercial landscape surrounding them is rapidly changing. Over 60 candidates in the works, with a few in Phase III clinical trials, the industry is increasingly …